Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 278

1.

JCEM Editor's Swan Song: 2015-2019.

Robertson RP.

J Clin Endocrinol Metab. 2019 Dec 1;104(12):6275-6278. doi: 10.1210/jc.2019-01927. No abstract available.

PMID:
31677602
2.

Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Biondi B, Kahaly GJ, Robertson RP.

Endocr Rev. 2019 Jun 1;40(3):789-824. doi: 10.1210/er.2018-00163. Review.

PMID:
30649221
3.

Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions.

Rickels MR, Robertson RP.

Endocr Rev. 2019 Apr 1;40(2):631-668. doi: 10.1210/er.2018-00154. Review.

PMID:
30541144
4.

Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.

Ruetten H, Gebauer M, Raymond RH, Calle RA, Cobelli C, Ghosh A, Robertson RP, Shankar SS, Staten MA, Stefanovski D, Vella A, Wright K, Fryburg DA; Foundation for the NIH Biomarkers Consortium Beta Cell Project Team.

Metab Syndr Relat Disord. 2018 Oct;16(8):406-415. doi: 10.1089/met.2018.0022. Epub 2018 Aug 17. Erratum in: Metab Syndr Relat Disord. 2019 Mar;17(2):128.

5.

Outpatient versus inpatient mixed meal tolerance and arginine stimulation testing yields comparable measures of variability for assessment of beta cell function.

Shankar SS, Lee DS, Raymond RH, Calle RA, Cobelli C, Ghosh A, Robertson RP, Ruetten H, Staten MA, Stefanovski D, Vella A, Whitaker S, Fryburg DA; Foundation for the NIH Biomarkers Consortium Beta Cell Project Team.

Contemp Clin Trials Commun. 2018 Mar 29;10:94-99. doi: 10.1016/j.conctc.2018.03.009. eCollection 2018 Jun.

6.

Deficient Glucagon Response to Hypoglycemia During a Mixed Meal in Total Pancreatectomy/Islet Autotransplantation Recipients.

Bogachus LD, Bellin MD, Vella A, Robertson RP.

J Clin Endocrinol Metab. 2018 Apr 1;103(4):1522-1529. doi: 10.1210/jc.2017-02182.

7.

Nrf2/antioxidant pathway mediates β cell self-repair after damage by high-fat diet-induced oxidative stress.

Abebe T, Mahadevan J, Bogachus L, Hahn S, Black M, Oseid E, Urano F, Cirulli V, Robertson RP.

JCI Insight. 2017 Dec 21;2(24). pii: 92854. doi: 10.1172/jci.insight.92854.

8.

Deficient Endogenous Glucose Production During Exercise After Total Pancreatectomy/Islet Autotransplantation.

Bogachus LD, Oseid E, Bellin M, Vella A, Robertson RP.

J Clin Endocrinol Metab. 2017 Sep 1;102(9):3288-3295. doi: 10.1210/jc.2017-00923.

9.

The COX-2/PGE2/EP3/Gi/o/cAMP/GSIS Pathway in the Islet: The Beat Goes On.

Robertson RP.

Diabetes. 2017 Jun;66(6):1464-1466. doi: 10.2337/dbi17-0017. No abstract available.

10.

Silymarin Activates c-AMP Phosphodiesterase and Stimulates Insulin Secretion in a Glucose-Dependent Manner in HIT-T15 Cells.

Meng R, Mahadevan J, Oseid E, Vallerie S, Robertson RP.

Antioxidants (Basel). 2016 Dec 12;5(4). pii: E47.

11.

Spontaneous Hypoglycemia After Islet Transplantation: The Case For Using Non-Hepatic Sites.

Robertson RP.

J Clin Endocrinol Metab. 2016 Oct;101(10):3571-3574. Epub 2016 Sep 9. Review.

12.

Standardized Mixed-Meal Tolerance and Arginine Stimulation Tests Provide Reproducible and Complementary Measures of β-Cell Function: Results From the Foundation for the National Institutes of Health Biomarkers Consortium Investigative Series.

Shankar SS, Vella A, Raymond RH, Staten MA, Calle RA, Bergman RN, Cao C, Chen D, Cobelli C, Dalla Man C, Deeg M, Dong JQ, Lee DS, Polidori D, Robertson RP, Ruetten H, Stefanovski D, Vassileva MT, Weir GC, Fryburg DA; Foundation for the National Institutes of Health β-Cell Project Team.

Diabetes Care. 2016 Sep;39(9):1602-13. doi: 10.2337/dc15-0931. Epub 2016 Jul 12.

13.

Early Alterations in Glycemic Control and Pancreatic Endocrine Function in Nondiabetic Patients With Chronic Pancreatitis.

Lundberg R, Beilman GJ, Dunn TB, Pruett TL, Freeman ML, Ptacek PE, Berry KL, Robertson RP, Moran A, Bellin MD.

Pancreas. 2016 Apr;45(4):565-71. doi: 10.1097/MPA.0000000000000491.

14.

Précis for JCEM: No Empty Promises.

Robertson RP.

J Clin Endocrinol Metab. 2016 Feb;101(2):416. doi: 10.1210/jc.2016-1080. No abstract available.

PMID:
26840100
15.

Factors Predicting Outcomes After a Total Pancreatectomy and Islet Autotransplantation Lessons Learned From Over 500 Cases.

Chinnakotla S, Beilman GJ, Dunn TB, Bellin MD, Freeman ML, Radosevich DM, Arain M, Amateau SK, Mallery JS, Schwarzenberg SJ, Clavel A, Wilhelm J, Robertson RP, Berry L, Cook M, Hering BJ, Sutherland DE, Pruett TL.

Ann Surg. 2015 Oct;262(4):610-22. doi: 10.1097/SLA.0000000000001453.

16.
17.

Total pancreatectomy and islet autotransplantation for chronic pancreatitis: breaking down barriers.

Robertson RP.

J Clin Endocrinol Metab. 2015 May;100(5):1762-3. doi: 10.1210/jc.2015-1876. No abstract available.

PMID:
25955323
18.

Puzzling about partial glucagon responses to hypoglycemia in intrahepatic islet recipients: missing pieces.

Robertson RP.

Diabetes. 2015 May;64(5):1511-2. doi: 10.2337/db15-0040. No abstract available.

19.

Research funding and ageism.

Robertson RP.

J Clin Endocrinol Metab. 2015 Feb;100(2):398-9. doi: 10.1210/jc.2015-1069. No abstract available.

PMID:
25658153
20.

Continuing the JCEM mission with its new editorial team.

Robertson RP.

J Clin Endocrinol Metab. 2015 Jan;100(1):53-4. doi: 10.1210/jc.2014-4224. No abstract available.

PMID:
25559531
21.

Assessment of β-cell mass and α- and β-cell survival and function by arginine stimulation in human autologous islet recipients.

Robertson RP, Bogachus LD, Oseid E, Parazzoli S, Patti ME, Rickels MR, Schuetz C, Dunn T, Pruett T, Balamurugan AN, Sutherland DE, Beilman G, Bellin MD.

Diabetes. 2015 Feb;64(2):565-72. doi: 10.2337/db14-0690. Epub 2014 Sep 3.

22.

Arginine is preferred to glucagon for stimulation testing of β-cell function.

Robertson RP, Raymond RH, Lee DS, Calle RA, Ghosh A, Savage PJ, Shankar SS, Vassileva MT, Weir GC, Fryburg DA; Beta Cell Project Team of the Foundation for the NIH Biomarkers Consortium.

Am J Physiol Endocrinol Metab. 2014 Oct 15;307(8):E720-7. doi: 10.1152/ajpendo.00149.2014. Epub 2014 Aug 26.

23.

Defective glucagon secretion during hypoglycemia after intrahepatic but not nonhepatic islet autotransplantation.

Bellin MD, Parazzoli S, Oseid E, Bogachus LD, Schuetz C, Patti ME, Dunn T, Pruett T, Balamurugan AN, Hering B, Beilman G, Sutherland DE, Robertson RP.

Am J Transplant. 2014 Aug;14(8):1880-6.

24.

Total pancreatectomy and islet autotransplantation in chronic pancreatitis: recommendations from PancreasFest.

Bellin MD, Freeman ML, Gelrud A, Slivka A, Clavel A, Humar A, Schwarzenberg SJ, Lowe ME, Rickels MR, Whitcomb DC, Matthews JB; PancreasFest Recommendation Conference Participants, Amann S, Andersen DK, Anderson MA, Baillie J, Block G, Brand R, Chari S, Cook M, Cote GA, Dunn T, Frulloni L, Greer JB, Hollingsworth MA, Kim KM, Larson A, Lerch MM, Lin T, Muniraj T, Robertson RP, Sclair S, Singh S, Stopczynski R, Toledo FG, Wilcox CM, Windsor J, Yadav D.

Pancreatology. 2014 Jan-Feb;14(1):27-35. doi: 10.1016/j.pan.2013.10.009. Epub 2013 Nov 13.

25.

Red wine and diabetes health: getting skin in the game.

Robertson RP.

Diabetes. 2014 Jan;63(1):31-8. doi: 10.2337/db13-1318. Review. No abstract available.

26.

Metabolic assessment prior to total pancreatectomy and islet autotransplant: utility, limitations and potential.

Lundberg R, Beilman GJ, Dunn TB, Pruett TL, Chinnakotla SC, Radosevich DM, Robertson RP, Ptacek P, Balamurugan AN, Wilhelm JJ, Hering BJ, Sutherland DE, Moran A, Bellin MD.

Am J Transplant. 2013 Oct;13(10):2664-71. doi: 10.1111/ajt.12392. Epub 2013 Aug 7.

27.

Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012.

Rickels MR, Bellin M, Toledo FG, Robertson RP, Andersen DK, Chari ST, Brand R, Frulloni L, Anderson MA, Whitcomb DC; PancreasFest Recommendation Conference Participants.

Pancreatology. 2013 Jul-Aug;13(4):336-42. doi: 10.1016/j.pan.2013.05.002. Epub 2013 May 17.

28.

Inactivation of specific β cell transcription factors in type 2 diabetes.

Guo S, Dai C, Guo M, Taylor B, Harmon JS, Sander M, Robertson RP, Powers AC, Stein R.

J Clin Invest. 2013 Aug;123(8):3305-16. doi: 10.1172/JCI65390. Epub 2013 Jul 1.

29.

Ebselen treatment prevents islet apoptosis, maintains intranuclear Pdx-1 and MafA levels, and preserves β-cell mass and function in ZDF rats.

Mahadevan J, Parazzoli S, Oseid E, Hertzel AV, Bernlohr DA, Vallerie SN, Liu CQ, Lopez M, Harmon JS, Robertson RP.

Diabetes. 2013 Oct;62(10):3582-8. doi: 10.2337/db13-0357. Epub 2013 Jun 25.

30.

Pancreatectomy and autologous islet transplantation for painful chronic pancreatitis: indications and outcomes.

Bellin MD, Sutherland DE, Robertson RP.

Hosp Pract (1995). 2012 Aug;40(3):80-7. doi: 10.3810/hp.2012.08.992. Review.

PMID:
23086097
31.

Beta cell nuclear musculoaponeurotic fibrosarcoma oncogene family A (MafA) is deficient in type 2 diabetes.

Butler AE, Robertson RP, Hernandez R, Matveyenko AV, Gurlo T, Butler PC.

Diabetologia. 2012 Nov;55(11):2985-8. doi: 10.1007/s00125-012-2666-2. Epub 2012 Jul 31.

32.

Cyclooxygenase-2, not microsomal prostaglandin E synthase-1, is the mechanism for interleukin-1β-induced prostaglandin E2 production and inhibition of insulin secretion in pancreatic islets.

Parazzoli S, Harmon JS, Vallerie SN, Zhang T, Zhou H, Robertson RP.

J Biol Chem. 2012 Sep 14;287(38):32246-53. doi: 10.1074/jbc.M112.364612. Epub 2012 Jul 20.

33.

The B55α-containing PP2A holoenzyme dephosphorylates FOXO1 in islet β-cells under oxidative stress.

Yan L, Guo S, Brault M, Harmon J, Robertson RP, Hamid R, Stein R, Yang E.

Biochem J. 2012 Jun 1;444(2):239-47. doi: 10.1042/BJ20111606.

34.

The battered β-cell: usual suspects and guilt by association.

Robertson RP.

J Clin Endocrinol Metab. 2011 Dec;96(12):3672-4. doi: 10.1210/jc.2011-2960. No abstract available.

35.

A role for zinc in pancreatic islet β-cell cross-talk with the α-cell during hypoglycaemia.

Robertson RP, Zhou H, Slucca M.

Diabetes Obes Metab. 2011 Oct;13 Suppl 1:106-11. doi: 10.1111/j.1463-1326.2011.01448.x. Review.

PMID:
21824263
36.

The welcome resurgence of the α-cell: a pro glucagon commentary.

Robertson RP.

Diabetes. 2010 Nov;59(11):2735-6. doi: 10.2337/db10-1238. No abstract available.

37.

Update on transplanting beta cells for reversing type 1 diabetes.

Robertson RP.

Endocrinol Metab Clin North Am. 2010 Sep;39(3):655-67. doi: 10.1016/j.ecl.2010.05.010. Review.

PMID:
20723826
38.

Islet transplantation a decade later and strategies for filling a half-full glass.

Robertson RP.

Diabetes. 2010 Jun;59(6):1285-91. doi: 10.2337/db09-1846. Review.

40.

Diabetes: Strategies to prevent the type 2 diabetes mellitus epidemic.

Robertson RP, Kendall DM, Seaquist ER.

Nat Rev Endocrinol. 2010 Mar;6(3):128-9. doi: 10.1038/nrendo.2010.2. No abstract available.

PMID:
20173772
41.

How do we define cure of diabetes?

Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, McLaughlin S, Phillips GL 2nd, Robertson RP, Rubino F, Kahn R, Kirkman MS.

Diabetes Care. 2009 Nov;32(11):2133-5. doi: 10.2337/dc09-9036. No abstract available.

42.

beta-Cell-specific overexpression of glutathione peroxidase preserves intranuclear MafA and reverses diabetes in db/db mice.

Harmon JS, Bogdani M, Parazzoli SD, Mak SS, Oseid EA, Berghmans M, Leboeuf RC, Robertson RP.

Endocrinology. 2009 Nov;150(11):4855-62. doi: 10.1210/en.2009-0708. Epub 2009 Oct 9.

43.

ATP-sensitive K+ channel mediates the zinc switch-off signal for glucagon response during glucose deprivation.

Slucca M, Harmon JS, Oseid EA, Bryan J, Robertson RP.

Diabetes. 2010 Jan;59(1):128-34. doi: 10.2337/db09-1098. Epub 2009 Oct 6.

44.

2009 Presidential Address: mentoring ... touching the future.

Robertson RP.

Diabetes. 2009 Oct;58(10):2165-7. doi: 10.2337/db09-9029. No abstract available.

45.

2009 presidential address: mentoring ... touching the future.

Robertson RP.

Diabetes Care. 2009 Oct;32(10):1938-40. doi: 10.2337/dc09-9035. No abstract available.

46.

Beta-cell deterioration during diabetes: what's in the gun?

Robertson RP.

Trends Endocrinol Metab. 2009 Oct;20(8):388-93. doi: 10.1016/j.tem.2009.05.004. Epub 2009 Sep 11. Review.

47.

Editorial: Update on stem cell research.

Robertson RP, Giudice LC.

Endocr Rev. 2009 May;30(3):203. doi: 10.1210/er.2009-0020. No abstract available.

PMID:
19433633
48.

ADA research funding in 2009: where will we be?

Robertson RP.

Diabetes. 2009 Jan;58(1):1. doi: 10.2337/db08-1395. No abstract available.

49.

ADA research funding in 2009: where will we be?

Robertson RP.

Diabetes Care. 2009 Jan;32(1):206. doi: 10.2337/dc08-1846. No abstract available.

50.

Novel Nonimmunological Forms of {beta}-Cell Dysfunction: Diabetic Syndromes and Pathogenic Mechanisms.

Robertson RP, Aguilar-Bryan L.

Endocr Rev. 2008 May;29(3):253. doi: 10.1210/er.2008-0012. No abstract available.

PMID:
18480303

Supplemental Content

Loading ...
Support Center